Signant Health brings its eConsent solution to China

Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC). This landmark investigator-led Schizophrenia trial, which will enroll hundreds of patients at multiple sites, will be the first study to implement Signant's TrialConsent solution in China. SMHC is an affiliate of Shanghai Jiao Tong University, one of the most elite research universities in the world, and a leading organization on mental health prevention planning. Using multimedia videos, knowledge quizzes, self-paced content review, and other patient-centric eConsent capabilities, TrialConsent will help people considering enrolling in the trial and their families understand expectations, risks, and benefits in order to make an educated participation decision. This means patients will be more engaged with sites from the beginning, which supports patient retention throughout the study. At the same time, SMHC will benefit from a collaborative consent design process with IRBs and other stakeholders, real-time review of incoming patient consent and compliance data, and automated document management to prevent most consent-related audit findings. Dr. Shen, Associate Professor and Vice Director of medical psychology in the Mental Health Department at Shanghai Jiaotong University, and Vice Director of the Department of Psychology at the Shanghai Mental Health Center, said, "Signant Health, with global operations across thousands of sites, was selected for its pioneering patient facing clinical trial technologies, for understanding the unique needs of clinical trials in Asia-Pacific, and most notably proven scientific capabilities across the complex field of neuroscience. SMHC was confident Signant could support the large-scale investigator led study involving several hundred subjects across numerous hospital sites, generating significant data. Robust data collection is critical and patient-centric digitization of the eConsent process will deliver enormous benefit to all stakeholders in this important study."

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001191 seconds